The Lancet Gastroenterology & Hepatology Journal Cover November 1st 2017
figureposted on 06.12.2017, 10:57 by Andrew SelbyAndrew Selby
Laparoscopic ileocaecal resection versus infiximab for terminal ileitis in Crohn’s disease: a randomised controlled, open-label, multicentre trial. Treatment of patients with ileocaecal Crohn’s disease who have not responded to conventional therapy is commonly scaled up to biological agents, but surgery can also ofer excellent short-term and long-term results. We compared laparoscopic ileocaecal resection with infiximab to assess how they afect health-related quality-of-life.
Dr Robert Brierley, Dr Heather Van Epps
- The Arts, English and Drama